-
Product Insights
Neonatal Respiratory Distress Syndrome Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2020" provides an overview of Neonatal Respiratory Distress Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Obstructive Sleep Apnea Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2020" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Sleep Apnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease and is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, 2019). IPF is associated with a poor prognosis, with a median survival of three to five years (Raghu et al.,...
-
Product Insights
Acute Respiratory Distress Syndrome Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2020" provides an overview of Acute Respiratory Distress Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The acute respiratory distress syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute...
-
Product Insights
Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bronchopulmonary dysplasia (BPD) can occur with multiple symptoms including tachypnea, tachycardia, increased respiratory effort (with retractions, nasal flaring, and grunting), and bluish skin color. The Treatment of BPD includes bronchodilators, diuretics, and antibiotics. The Bronchopulmonary Dysplasia pipeline market research report provides an overview of the Bronchopulmonary Dysplasia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchopulmonary Dysplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and...
-
Product Insights
Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cough can occur with many signs and symptoms which include stuffy nose, hoarseness, wheezing and shortness of breath, and heartburn or a sour taste in the mouth. The treatment for cough entails antihistamines, decongestants, antibiotics, and cough suppressants. The Cough pipeline market research report provides an overview of the Cough pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
-
Product Insights
Malignant Pleural Effusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Malignant Pleural Effusion pipeline market report provides a comprehensive overview of the therapeutics under development for Malignant Pleural Effusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Malignant Pleural...
-
Product Insights
Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lung Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lung Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Asthma Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2016" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.